FDA allows emergency use of remdesivir to treat coronavirus patients after promising study

FDA allows emergency use of remdesivir to treat coronavirus patients after promising study



President Trump announced Friday that the Food and Drug Administration (FDA) has authorized the emergency use of Gilead Science's experimental antiviral drug remdesivir to treat coronavirus patients after early results of a clinical study indicated the drug helps speed recovery.